|
| 1 |
The Efficacy of Treatment Intensification by Quadruple Oral Therapy Compared to GLP-1RA Therapy in Poorly Controlled Type 2 Diabetes Mellitus Patients: A Real-World Data Study
Minyoung Kim, Hosu Kim, Kyong Young Kim, Soo Kyoung Kim, Junghwa Jung, Jong Ryeal Hahm, Jaehoon Jung, Jong Ha Baek
Diabetes Metab J.2023;47(1):135-139. Published online 2022 April 29
DOI: http://dx.doi.org/10.4093/dmj.2021.0373
|
|
| 2 |
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
Bo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, Jung-Hyun Noh, Cheol-Young Park, Hyeong-Kyu Park, Kee-Ho Song, Jong Chul Won, Jae Myung Yu, Mi Young Lee, Jae Hyuk Lee, Soo Lim, Sung Wan Chun, In-Kyung Jeong, Choon Hee Chung, Seung Jin Han, Hee-Seok Kim, Ju-Young Min, Sungrae Kim
|
|
| 3 |
Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
Seung Eun Lee, Hyewon Nam, Han Seok Choi, Hoseob Kim, Dae-Sung Kyoung, Kyoung-Ah Kim
Diabetes Metab J.2022;46(4):567-577. Published online 2022 February 8
DOI: http://dx.doi.org/10.4093/dmj.2021.0160
|
|
| 4 |
Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
Jeonghoon Ha, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Seung Hyun Ko, Moo Il Kang, Sung Dae Moon, Ki-Hyun Baek
Endocrinol Metab.2021;36(4):895-903. Published online 2021 August 9
DOI: http://dx.doi.org/10.3803/EnM.2021.1026
|
|
| 5 |
Recent Perspective on Thiazolidinedione
Won Jun Kim
|
|
| 6 |
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
Jaehyun Bae, Taegyun Park, Hyeyoung Kim, Minyoung Lee, Bong-Soo Cha
Diabetes Metab J.2021;45(3):326-336. Published online 2021 April 19
DOI: http://dx.doi.org/10.4093/dmj.2020.0272
|
|
| 7 |
Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim
|
|
| 8 |
Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease
Hyekyung Yang, Cheol-Young Park
|
|
| 9 |
Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
|
|
| 10 |
Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
Kyoung Min Kim, Hyun-Jin Jin, Seo Yeon Lee, Hyo Jin Maeng, Gha Young Lee, Tae Jung Oh, Sung Hee Choi, Hak Chul Jang, Soo Lim
Endocrinol Metab.2017;32(3):389-395. Published online 2017 September 18
DOI: http://dx.doi.org/10.3803/EnM.2017.32.3.389
|
|
| 11 |
Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
Nam Hoon Kim, Dong-Lim Kim, Kyeong Jin Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim
|
|
| 12 |
Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Jong Ho Kim, Sang Soo Kim, Hong Sun Baek, In Kyu Lee, Dong Jin Chung, Ho Sang Sohn, Hak Yeon Bae, Mi Kyung Kim, Jeong Hyun Park, Young Sik Choi, Young Il Kim, Jong Ryeal Hahm, Chang Won Lee, Sung Rae Jo, Mi Kyung Park, Kwang Jae Lee, In Joo Kim
|
|
| 13 |
Retrospective Observational Dose-Titration Study of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on 15 mg of Pioglitazone
So Young Ha, Hae Won Jung, Yong Jun Choi, Hyun Kyo Lee, Jong Wook Choi, Ji Hoon Choi, Jung Hyun Noh, Jae Won Hong, Dong-Jun Kim
|
|
| 14 |
Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
Cesar Corzo, Patrick R. Griffin
|
|
| 15 |
Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
Kyeong Won Lee, Yun Hyi Ku, Min Kim, Byung Yong Ahn, Sung Soo Chung, Kyong Soo Park
|
|
| 16 |
Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus
Sun Woo Kim
|
|
| 17 |
Short Insulin Tolerance Test Can Determine the Effects of Thiazolidinediones Treatment in Type 2 Diabetes
Mi Young Lee, Jang Hyun Koh, Soo Min Nam, Pil Moon Jung, Joong Kyung Sung, Song Yi Kim, Jang Yel Shin, Young Goo Shin, Choon Hee Chung
Yonsei Med J.2008;49(6):901-908. Published online 2008 December 31
DOI: http://dx.doi.org/10.3349/ymj.2008.49.6.901
|
|
| 18 |
Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF Rats
Mi Young Lee, Eun Young Lee, Byung Jun Lee, Chan Sik Won, Jang Hyun Koh, Jang Yel Shin, Young Goo Shin, Byung Pil Cho, Choon Hee Chung
Yonsei Med J.2007;48(2):301-307. Published online 2007 April 30
DOI: http://dx.doi.org/10.3349/ymj.2007.48.2.301
|
|
| 19 |
Thiazolidinediones on Insulin Resistance and Insulin Secretion in Obese Diabetic OLETF Rats
Jung-hyun Noh, Seung-hyun Hong, Kyoung-hee Lee, Kyoung-Min Min, Tae-young Yang, Myung-shik Lee, Kwang-won Kim, Moon-kyu Lee
|
|
